Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Parkinson's disease].

K Miyoshi1

  • 1Hyogo Institute for Aging Brain & Cognitive Disorders.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 25, 2001
PubMed
Summary
This summary is machine-generated.

Depression affects nearly 30% of Parkinson's patients, presenting with common symptoms like fatigue and loss of interest. Treatment options include serotonin reuptake inhibitors and selegiline.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breath-hold diffusion-weighted MR imaging (DWI) using deep learning reconstruction: Comparison with navigator triggered DWI in patients with malignant liver tumors.

Radiography (London, England : 1995)·2024
Same author

High resolution x-ray absorption and emission spectroscopy of Li <sub>x</sub> CoO<sub>2</sub> single crystals as a function delithiation.

Journal of physics. Condensed matter : an Institute of Physics journal·2017
Same author

Usefulness of the renal resistive index to predict an increase in urinary albumin excretion in patients with essential hypertension.

Journal of human hypertension·2016
Same author

Therapeutic Effect of Sirolimus for Lymphangioleiomyomatosis Remaining in the Abdominopelvic Region After Lung Transplantation: A Case Report.

Transplantation proceedings·2016
Same author

Isolation and characterization of dental epithelial cells derived from amelogenesis imperfecta rat.

Oral diseases·2015
Same author

Generation of α-1,3-Galactosyltransferase-Deficient Porcine Embryonic Fibroblasts by CRISPR/Cas9-Mediated Knock-in of a Small Mutated Sequence and a Targeted Toxin-Based Selection System.

Reproduction in domestic animals = Zuchthygiene·2015
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Neurology
  • Psychiatry

Context:

  • Parkinson's disease is a neurodegenerative disorder.
  • Depression is a common comorbidity in Parkinson's disease.

Purpose:

  • To summarize the prevalence, symptoms, and treatment of depression in Parkinson's disease patients.

Summary:

  • Approximately 30% of Parkinson's patients experience depression.
  • Common symptoms include loss of interest, fatigue, and psychomotor retardation.
  • Somatic symptoms are frequent, while suicidal ideation is less common than in endogenous depression.
  • Serotonin reuptake inhibitors and selegiline are recommended treatments.

Impact:

  • Informs clinical practice for managing Parkinson's disease patients with depression.
  • Highlights the importance of recognizing and treating psychiatric complications in neurodegenerative disorders.